Bio-Rad Laboratories is a U.S.-based IVD and life science company with revenues of approximately $2.4 billion in 2025 across clinical diagnostics and life science research. Bio-Rad's clinical diagnostics segment specializes in quality controls, blood typing, diabetes monitoring (HbA1c), autoimmune testing, and infectious disease serology. The company is the global leader in laboratory quality controls — a high-margin, recurring revenue business supplying calibrators and controls to virtually every clinical laboratory globally. Bio-Rad accepted a binding offer to acquire Stilla Technologies in February 2025, expanding into digital PCR. The company's Droplet Digital PCR technology is gaining adoption in oncology research and liquid biopsy applications.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Strategic Directions — Quality Controls Leadership, Digital PCR Expansion, and Autoimmune Testing Through 2030
• Financial Performance — Revenue, Revenue by Segment, Revenue by Geography, EBITDA, and R&D 2023-2025
• SWOT Analysis — Competitive Advantages, Structural Vulnerabilities, Opportunities, and Risks
• Technological Know-How — Quality Controls, ddPCR, Blood Typing, and HbA1c Platforms
• Latest Products and Services — Stilla Integration, New Assays, and Innovation Pipeline
• M&A — Stilla Technologies Acquisition, Joint Ventures, and Partnerships 2023-2025
• Marketing Tactics — Quality Controls Market Strategy and Life Science Channel
• Organization and Management — Leadership, Structure, and Workforce
Table of Contents
1. Executive Summary
2. Strategic Directions
3. Financial Performance
4. SWOT Analysis
5. Technological Know-How
6. Latest Products and Services
7. M&A
8. Marketing Tactics
9. Organization and Management
10. Appendix
List of Tables
Table 1. Bio-Rad Laboratories — Key Financial Metrics Summary 2023-2025
Table 2. Bio-Rad Laboratories — Revenue by Segment 2023-2025
Table 3. Bio-Rad Laboratories — Revenue by Geography 2023-2025
Table 4. Bio-Rad Laboratories — R&D Investment 2023-2025
Table 5. Bio-Rad Laboratories — SWOT Analysis
Table 6. Bio-Rad Laboratories — Core Technology Capabilities and Key Platforms
Table 7. Bio-Rad Laboratories — Key Analyzers and Reagent Portfolio
Table 8. Bio-Rad Laboratories — M&A Activity Summary 2023-2025
Table 9. Bio-Rad Laboratories — Key Management and Leadership
Table 10. Bio-Rad Laboratories — Strategic Priorities 2025-2030
